Fangfang Bu

486 total citations
9 papers, 285 citations indexed

About

Fangfang Bu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fangfang Bu has authored 9 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Fangfang Bu's work include Cancer-related Molecular Pathways (3 papers), Epigenetics and DNA Methylation (2 papers) and Circular RNAs in diseases (2 papers). Fangfang Bu is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Epigenetics and DNA Methylation (2 papers) and Circular RNAs in diseases (2 papers). Fangfang Bu collaborates with scholars based in China, Philippines and United Kingdom. Fangfang Bu's co-authors include Xin Tong, Guobin Wu, Anmin Liang, Yajun Guo, Bin Lü, Mengchao Wu, Jian Zhao, Xin Lü, Lei Cao and Hui Mao and has published in prestigious journals such as Gastroenterology, Hepatology and Oncotarget.

In The Last Decade

Fangfang Bu

9 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangfang Bu China 8 173 107 90 53 32 9 285
Huita Wu China 7 189 1.1× 72 0.7× 93 1.0× 37 0.7× 79 2.5× 15 273
Mengxian Tu China 6 116 0.7× 46 0.4× 84 0.9× 45 0.8× 40 1.3× 8 225
Gaofeng Li China 9 224 1.3× 64 0.6× 151 1.7× 30 0.6× 57 1.8× 27 326
Yoshimoto Nomura Japan 7 195 1.1× 104 1.0× 103 1.1× 41 0.8× 36 1.1× 12 315
Thi Bich Uyen Le Singapore 9 268 1.5× 63 0.6× 64 0.7× 22 0.4× 27 0.8× 11 336
Chi‐Hung Lin Taiwan 8 217 1.3× 63 0.6× 130 1.4× 54 1.0× 16 0.5× 12 344
Yeben Qian China 12 158 0.9× 56 0.5× 95 1.1× 50 0.9× 37 1.2× 24 334
Wei Luan China 8 145 0.8× 137 1.3× 93 1.0× 32 0.6× 17 0.5× 22 292
Jianjun Xiao China 9 89 0.5× 115 1.1× 75 0.8× 24 0.5× 72 2.3× 16 222
Xudong Chen China 12 222 1.3× 79 0.7× 203 2.3× 21 0.4× 42 1.3× 21 348

Countries citing papers authored by Fangfang Bu

Since Specialization
Citations

This map shows the geographic impact of Fangfang Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Bu more than expected).

Fields of papers citing papers by Fangfang Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangfang Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Bu. The network helps show where Fangfang Bu may publish in the future.

Co-authorship network of co-authors of Fangfang Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Bu. A scholar is included among the top collaborators of Fangfang Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Bu. Fangfang Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bu, Fangfang, et al.. (2025). Severe reversible cardiomyopathy associated with adrenal crisis caused by isolated adrenocorticotropin deficiency: a case report. Frontiers in Cardiovascular Medicine. 12. 1451635–1451635. 1 indexed citations
2.
Chen, Yan, Junjie Hu, Fangfang Bu, et al.. (2020). Clinical characteristics of hyperprogressive disease in NSCLC after treatment with immune checkpoint inhibitor: a systematic review and meta-analysis. BMC Cancer. 20(1). 707–707. 26 indexed citations
3.
Liu, Yang, et al.. (2018). MicroRNA‑221‑3p contributes to cardiomyocyte injury in H2O2‑treated H9c2 cells and a rat model of myocardial ischemia‑reperfusion by targeting p57. International Journal of Molecular Medicine. 42(1). 589–596. 12 indexed citations
4.
Mao, Hui, Fei Pan, Fangfang Bu, et al.. (2016). Feedback mechanisms between M2 macrophages and Th17 cells in colorectal cancer patients. Tumor Biology. 37(9). 12223–12230. 19 indexed citations
5.
Pan, Fei, Hui Mao, Fangfang Bu, et al.. (2016). Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma. Oncotarget. 8(4). 5735–5752. 49 indexed citations
6.
Bu, Fangfang, Xing Liu, Jingjing Li, et al.. (2014). TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma. Oncotarget. 6(4). 2120–2133. 35 indexed citations
7.
Bu, Fangfang, et al.. (2014). Decreased RGS6 expression is associated with poor prognosis in pancreatic cancer patients.. PubMed. 7(7). 4120–7. 10 indexed citations
8.
Lu, Bin, Huaizu Guo, Jian Zhao, et al.. (2010). Increased Expression of iASPP, Regulated by Hepatitis B Virus X Protein-Mediated NF-κB Activation, in Hepatocellular Carcinoma. Gastroenterology. 139(6). 2183–2194.e5. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026